Stepwise specification of lymphocyte developmental lineages

Current Opinion in Genetics and Development

Volumn 10, Issue 4, 2000, Pages 370-379

  Rothenberg, Ellen V ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR;

B LYMPHOCYTE DIFFERENTIATION; CELL LINE; GENE EXPRESSION; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; PROLYMPHOCYTE; REVIEW; T LYMPHOCYTE;

EID: 0033933855     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(00)00098-8     Document Type: Review

References (84)

1. Spits H., Blom B., Jaleco A.C., Weijer K., Verschuren M.C., van Dongen J.J., Heemskerk M.H., Res P.C. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev. 165:1998;75-86.
2. Shortman K., Vremec D., Corcoran L.M., Georgopoulos K., Lucas K., Wu L. The linkage between T-cell and dendritic cell development in the mouse thymus. Immunol Rev. 165:1998;39-46.
3. Rodewald H-R., Fehling H.J. Molecular and cellular events in early thymocyte development. Adv Immunol. 69:1998;1-112.
4. Rothenberg E.V., Telfer J.C., Anderson M.K. Transcriptional regulation of lymphocyte lineage commitment. Bioessays. 21:1999;726-742. This review presents in full the case for the distinction between T-lineage specification and commitment based on the timing of gene expression changes between thymocyte subsets of defined developmental potential. The function of transcription factors like GATA-1 and PU.1 that work as "central lineage regulators" is defined in terms of their effects on other transcription factors and on growth factor requirements, over and above their abilities to turn on lineage-specific target genes. This provides the context for a consideration of the regulatory pathways known to initiate B and T cell differentiation.
5. dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood. 87:1996;5196-5206.
6. •].
7. •]) to establish the conserved developmental relationship between these two cell types.
8. Lucas K., Vremec D., Wu L., Shortman K. A linkage between dendritic cell and T-cell development in the mouse thymus: the capacity of sequential T-cell precursors to form dendritic cells in culture. Dev Comp Immunol. 22:1998;339-349.
9. •], this offers evidence that the T/dendritic cell split can precede the T/NK split.
10. Carlyle J.R., Michie A.M., Furlonger C., Nakano T., Lenardo M.J., Paige C.J., Zúñiga-Pflücker J.C. Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J Exp Med. 186:1997;173-182.
11. Kawamoto H., Ohmura K., Katsura Y. Direct evidence for the commitment of hematopoietic stem cells to T, B, and myeloid lineages in murine fetal liver. Int Immunol. 9:1997;1011-1019.
12. Kawamoto H., Ohmura K., Katsura Y. Cutting edge: presence of progenitors restricted to T, B, or myeloid lineage, but absence of multipotent stem cells, in the murine fetal thymus. J Immunol. 161:1998;3799-3802.
13. •].
14. •].
15. ••].).
16. Kee B.L., Paige C.J. In vitro tracking of IL-7 responsiveness and gene expression during commitment of bipotent B-cell/macrophage progenitors. Curr Biol. 6:1996;1159-1169.
17. Aiba Y., Ogawa M. Development of natural killer cells, B lymphocytes, macrophages, and mast cells from single hematopoietic progenitors in culture of murine fetal liver cells. Blood. 90:1997;3923-3930.
18. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 91:1997;661-672.
19. Lacaud G., Carlsson L., Keller G. Identification of a fetal hematopoietic precursor with B cell, T cell, and macrophage potential. Immunity. 9:1998;827-838.
20. + Pro-B cells can give rise to dendritic cells in vitro. J Immunol. 161:1998;5795-5799.
21. hi cells coincides with commitment to the B cell lineage. Eur J Immunol. 28:1998;3850-3856.
22. - progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood. 93:1999;96-106. In an impressive advance, Miller et al. describe an in vitro system that supports the growth of single, sorted hematopoietic precursor cells and permits their differentiation into myeloid, lymphoid, and dendritic cells at once. The key is a new stromal cell line, AFT024, and carefully designed cytokine supplements that support high cloning efficiencies regardless of the developmental path the cells choose. This system makes it possible to prove lymphoid/myeloid multipotentiality of an immature human bone marrow cell type, and should be broadly applicable to other candidate precursor types.
23. Candéias S., Hardy R.R., Li Y.S., Staerz U.D. T cell receptor Vβ8.2 gene germ-line transcription: an early event of lymphocyte differentiation. Eur J Immunol. 24:1994;3073-3081.
24. Ismaili J., Antica M., Wu L. CD4 and CD8 expression and T cell antigen receptor gene rearrangement in early intrathymic precursor cells. Eur J Immunol. 26:1996;731-737.
25. Wang H., Diamond R.A., Rothenberg E.V. Cross-lineage expression of Ig-β (B29) in thymocytes: positive and negative gene regulation to establish T-cell identity. Proc Natl Acad Sci USA. 95:1998;6831-6836.
26. Wang H., Diamond R.A., Yang-Snyder J.A., Rothenberg E.V. Precocious expression of T-cell functional response genes in vivo in primitive thymocytes before T-lineage commitment. Int Immunol. 10:1998;1623-1635.
27. •]) but even express a gene widely thought to be a definitive marker of T-lineage commitment. This dramatic result could mean that pTα is expressed earlier in human T-cell development than in the mouse, where it is turned on only at the stage of specification [26]; alternatively, this could be emphatic evidence for the difference between T-lineage specification and T-lineage commitment.
28. Rothenberg E.V. Gene regulation in T-cell lineage commitment. Monroe J., Rothenberg E.V. Molecular Biology of B and T Cell Development. 1998;337-365 Humana Press, Totowa, NJ.
29. Bain G., Murre C. The role of E-proteins in B- and T-lymphocyte development. Semin Immunol. 10:1998;143-153.
30. Reya T., Grosschedl R. Transcriptional regulation of B-cell differentiation. Curr Opin Immunol. 10:1998;158-165.
31. O'Riordan M., Grosschedl R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity. 11:1999;21-31. Previous studies, reviewed in [30], have shown that both EBF and E2A are essential for the earliest events in B-lineage specification. Here, O'Riordan and Grosschedl show that the dependence on both genes is so acute that a mixed heterozygote shows a developmental block almost as severe as a complete knockout of either one. The onset of expression of RAG-1, RAG-2, the pre-B cell receptor gene λ5, and Pax5 is severely inhibited. This paper also shows that EBF directly transactivates Pax5 (also see [32]).
32. Kee B.L., Murre C. Induction of Early B Cell Factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J Exp Med. 188:1998;699-713.
33. Nutt S.L., Urbanek P., Rolink A., Busslinger M. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V- to-DJ recombination at the IgH locus. Genes Dev. 11:1997;476-491.
34. Nutt S.L., Morrison A.M., Dörfler P., Rolink A., Busslinger M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17:1998;2319-2333.
35. ••].
36. ••] show that the Pax5-deficient pro-B cells differ sharply from normal B-cell precursors with the same phenotype in that they are excellent, self-renewing precursors for all classes of T cells.
37. Cross M.A., Enver T. The lineage commitment of haemopoietic progenitor cells. Curr Opin Genet Dev. 7:1997;609-613.
38. Enver T., Greaves M. Loops, lineage, and leukaemia. Cell. 94:1998;9-12.
39. Wallin J.J., Gackstetter E.R., Koshland M.E. Dependence of BSAP repressor and activator functions on BSAP concentration. Science. 279:1998;1961-1964.
40. Chiang M.Y., Monroe J.G. BSAP/Pax5A expression blocks survival and expansion of early myeloid cells implicating its involvement in maintaining commitment to the B-lymphocyte lineage. Blood. 94:1999;3621-3632. Using a multipotent hematopoietic cell line undergoing myeloid differentiation in culture, Chiang and Monroe show an indirect way that Pax5 can enforce B cell lineage commitment - not by preventing the acquisition of a myeloid phenotype but by preventing growth and survival of cells taking a myeloid differentiation pathway. This result recalls the phenotype of proerythroblasts differentiating under the influence of GATA-2 instead of GATA-1 [41] and suggests that one way plasticity is terminated in hematopoietic development is through shifts in the regulatory state of cells that make lineage-inappropriate transcription factors become toxic.
41. Weiss M.J., Orkin S.H. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci USA. 92:1995;9623-9627.
42. Seshasayee D., Gaines P., Wojchowski D.M. GATA-1 dominantly activates a program of erythroid gene expression in factor-dependent myeloid FDCW2 cells. Mol Cell Biol. 18:1998;3278-3288.
43. •], this result supports the possibility that different multipotent precursors can segregate their developmental potentials in variable orders.
44. + Pro-T thymocytes. Proc Natl Acad Sci USA. 95:1998;12 522-12 527.
45. Bruno L., Scheffold A., Radbruch A., Owen M.J. Threshold of pre-T-cell receptor surface expression is associated with αβ T-cell lineage commitment. Curr Biol. 9:1999;559-568.
46. Wilson A., Capone M., MacDonald H.R. Unexpectedly late expression of intracellular CD3ε and TCR γδ proteins during adult thymus development. Int Immunol. 11:1999;1641-1650.
47. •].
48. •] emphasizing instructive signaling.
49. Deftos M.L., He Y-W., Ojala E.W., Bevan M.J. Correlating Notch signaling with thymocyte maturation. Immunity. 9:1998;777-786.
50. Jehn B.M., Bielke W., Pear W.S., Osborne B.A. Cutting edge: protective effects of Notch-1 on TCR-induced apoptosis. J Immunol. 162:1999;635-638.
51. Jones P., May G., Healy L., Brown J., Hoyne G., Delassus S., Enver T. Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. Blood. 92:1998;1505-1511.
52. Li L., Milner L.A., Deng Y., Iwata M., Banta A., Graf L., Marcovina S., Friedman C., Trask B.J., Hood L., Torok-Storb B. The human homolog of Rat Jagged1 expressed by bone marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity. 8:1998;43-55.
53. ••].
54. ••] demonstrate the sharply reciprocal effect of Notch1 signaling in B-cell and T-cell development. The dichotomous impact emphasizes cryptic dissimilarities between the B-cell and T-cell differentiation programs. The development of B cells or T cells in inappropriate tissues when Notch signaling is perturbed suggests that either the presence or absence of stimulatory Notch ligands is a key element distinguishing T-cell and B-cell inductive microenvironments.
55. ••].
56. ••].
57. ••] show that, in the absence of Hes1, lymphoid precursors are acutely disabled in their ability to differentiate into thymocytes, showing a block just at the stage when specification and early expansion normally take place. This effect on Hes1 mutant donor cells even when differentiating in a wildtype microenvironment proves that a critical Notch signal must be delivered in the T cell precursor itself.
58. Ordentlich P., Lin A., Shen C-P., Blaumueller C., Matsuno K., Artavanis-Tsakonas S., Kadesch T. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol. 18:1998;2230-2239.
59. •,69].
60. Bain B., Engel I., Robanus Maandag E.C., te Riele H.P., Voland J.R., Sharp L.L., Chun J., Huey B., Pinkel D., Murre C. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol. 17:1997;4782-4791.
61. Heemskerk M.H.M., Blom B., Nolan G., Stegmann A.P.A., Bakker A.Q., Weijer K., Res P.C.M., Spits H. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J Exp Med. 186:1997;1597-1602.
62. Hu M., Krause D., Greaves M., Sharkis S., Dexter M., Heyworth C., Enver T. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11:1997;774-785.
63. Anderson M.K., Hernandez-Hoyos G., Diamond R.A., Rothenberg E.V. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development. 126:1999;3131-3148. This paper introduces a new gene-discovery approach to the search for T-lineage transcriptional regulators and presents a comprehensive analysis of the expression of genes of the Ets family during the course of T-cell differentiation. This analysis shows a combinatorial 'Ets code' distinguishing early B, NK, and T precursors at different stages. The results demonstrate both the uniquely dynamic, transitional regulatory phase associated with T-lineage specification and the highly selective repression of PU.1 expression coinciding with lineage commitment.
64. Allen R.D. Jr., Bender T.P., Siu G. c-Myb is essential for early T cell development. Genes Dev. 13:1999;1073-1078. This paper shows that homozygous mutation of c-Myb blocks T-cell development at the earliest stage, leading to the loss of virtually all normal-phenotype T-cell precursors. The conclusion is based on chimeras with homozygous mutant embryonic stem cells, allowing the development of mutant cells to be tracked in a viable, largely normal microenvironment.
65. Barton K., Muthusamy N., Fischer C., Ting C-N., Walunas T.L., Lanier L.L., Leiden J.M. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 9:1998;555-563.
66. Yokota Y., Mansouri A., Mori S., Sugawara S., Adachi S., Nishikawa S-I., Gruss P. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 397:1999;702-706. This report illustrates that the Id inhibitory factors not only block T cell development, as shown in [61] but are required positively for NK cell development. Detailed analysis of the B and T-cell subsets in the Id2-mutant mice is still lacking but the report shows that lymphoid tissues are populated with a seemingly full complement of B and T cells.
67. Blom B., Heemskerk M.H.M., Verschuren M.C.M., van Dongen J.J.M., Stegmann A.P.A., Bakker A.Q., Couwenberg F., Res P.C.M., Spits H. Disruption of αβ but not of γδ T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors. EMBO J. 18:1999;2793-2802. This paper strikingly demonstrates that E2A-type bHLH proteins and their antagonists not only influence the T/NK lineage choice but also the choice of TCRαβ versus TCRγδ fates once within the thymus. (See also [69].).
68. Barndt R., Dai M.F., Zhang Y. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during αβ thymopoiesis. J Immunol. 163:1999;3331-3343. Here, a homozygous mutant of the major T-cell bHLH factor HEB is shown to retard T cell development but at a surprisingly late stage: in contrast to E2A mutants, which constrict the input of newly-specified T-cell precursors [60], the HEB mutants are slowed and inhibited in their transit through checkpoint 1.
69. Bain G., Romanow W.J., Albers K., Havran W.L., Murre C. Positive and negative regulation of V(D)J recombination by the E2A proteins. J Exp Med. 189:1999;289-300.
70. Tokoro Y., Sugawara T., Yaginuma H., Nakauchi H., Terhorst C., Wang B., Takahama Y. A mouse carrying genetic defect in the choice between T and B lymphocytes. J Immunol. 161:1998;4591-4598.
71. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404:2000;193-197. This paper is highly noteworthy for hematopoiesis in general; in the context of the present review, the most exciting feature is the comparative gene expression analysis of hematopoietic stem cells, committed common lymphoid progenitors, common myeloid (nonlymphoid) progenitors, and a variety of more narrowly focused intermediates. The results elegantly show the low-level expression of multilineage genes in the earliest precursors, followed by upregulation of these genes in the more committed precursors of the appropriate types and downregulation in those of inappropriate cell lineages.
72. Ting C-N., Olson M.C., Barton K.P., Leiden J.M. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature. 384:1996;474-478.
73. Hendriks R.W., Nawijn M.C., Engel J.D., van Doorninck H., Grosveld F., Karis A. Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur J Immunol. 29:1999;1912-1918. Here a powerful lacZ knock-in technology is used not only to monitor the expression of GATA-3 on a per cell basis but also to investigate the fates of the cells that would have developed into T cells when both alleles of GATA-3 are mutated. The lacZ detection is somewhat disappointing in sensitivity but the results are definitive enough to demonstrate that GATA-3 mutant precursors fail to populate the thymus with even the most primitive recognizable cell types.
74. Verbeek S., Izon D., Hofhuis F., Robanus-Maandag E., te Riele H., Van de Wetering M., Oosterwegel M., Wilson A., MacDonald H.R., Clevers H. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature. 374:1995;70-74.
75. Okamura R.M., Sigvardsson M., Galceran J., Verbeek S., Clevers H., Grosschedl R. Redundant regulation of T cell differentiation and TCRα gene expression by the transcription factors LEF-1 and TCF-1. Immunity. 8:1998;11-20.
76. Fisher R.C., Scott E.W. Role of PU.1 in hematopoiesis. Stem Cells. 16:1998;25-37.
77. Tenen D.G., Hromas R., Licht J.D., Zhang D-E. Transcription factors, normal myeloid development, and leukaemia. Blood. 90:1997;489-519.
78. •].
79. ••].
80. Spain L.M., Guerriero A., Kunjibettu S., Scott E.W. T cell development in PU.1-deficient mice. J Immunol. 163:1999;2681-2687. This paper provides striking evidence that PU.1 is only needed to provide positive functions for T-cell development in the stages prior to checkpoint 1. Using a fetal thymic organ culture system, Spain et al. show that in spite of the gross defect in thymocyte generation in the absence of PU.1, rare cells can break through and generate a burst of normal T-cell differentiation.
81. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
82. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J., Maki R.A. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:1996;5647-5658.
83. Washburn T., Schweighoffer E., Gridley T., Chang D., Fowlkes B.J., Cado D., Robey E. Notch activity influences the αβ versus γδ T cell lineage decision. Cell. 88:1997;833-843.
84. Maitra S., Atchison M. BSAP can repress enhancer activity by targeting PU.1 function. Mol Cell Biol. 20:2000;1911-1922.